APA (7th ed.) Citation

Kameda, S., Maeda, A., Maeda, S., Inoue, Y., Takahashi, K., Kageyama, A., . . . Fujii, T. (2024, February). Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: A two-centre observational study. BMC Nephrology.

Chicago Style (17th ed.) Citation

Kameda, Shinya, Akinori Maeda, Shun Maeda, Yutaro Inoue, Kazunari Takahashi, Akira Kageyama, Kent Doi, and Tomoko Fujii. "Dose of Nafamostat Mesylate During Continuous Kidney Replacement Therapy in Critically Ill Patients: A Two-centre Observational Study." BMC Nephrology Feb. 2024.

MLA (9th ed.) Citation

Kameda, Shinya, et al. "Dose of Nafamostat Mesylate During Continuous Kidney Replacement Therapy in Critically Ill Patients: A Two-centre Observational Study." BMC Nephrology, Feb. 2024.